Hudock Inc’s BioTelemetry, Inc. BEAT Stock Holding History

Hudock Inc’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-150	Closed	-$9K	–	745
2019 Q1	$9K	Buy	+150	New	+$10.3K	﹤0.01%	427

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hudock Inc's BEAT Position: Q2 2019 in Review

Hudock Inc sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 150 shares — an estimated $9K sold.

Hudock Inc first reported a position in BEAT in Q1 2019 and held it in 1 quarter. The position peaked at $9K in Q1 2019. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Hudock Inc reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Hudock Inc sold 150 BioTelemetry, Inc. shares in Q2 2019, an estimated $9K.
Hudock Inc first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 1 quarter.
Hudock Inc's BioTelemetry, Inc. position peaked at $9K in Q1 2019.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Hudock Inc's 13F filing for Q2 2019, filed 30 Jul 2019.